SAN

76.26

-0.55%↓

ARGX

769.6

-1.99%↓

SHL.DE

35.21

+1.18%↑

PHIA

23.31

+2.51%↑

FRE

38.79

+3%↑

SAN

76.26

-0.55%↓

ARGX

769.6

-1.99%↓

SHL.DE

35.21

+1.18%↑

PHIA

23.31

+2.51%↑

FRE

38.79

+3%↑

SAN

76.26

-0.55%↓

ARGX

769.6

-1.99%↓

SHL.DE

35.21

+1.18%↑

PHIA

23.31

+2.51%↑

FRE

38.79

+3%↑

SAN

76.26

-0.55%↓

ARGX

769.6

-1.99%↓

SHL.DE

35.21

+1.18%↑

PHIA

23.31

+2.51%↑

FRE

38.79

+3%↑

SAN

76.26

-0.55%↓

ARGX

769.6

-1.99%↓

SHL.DE

35.21

+1.18%↑

PHIA

23.31

+2.51%↑

FRE

38.79

+3%↑

Search

Fagron

Atidarymo kaina

SektoriusSveikatos priežiūra

24.35 -1.62

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

24.35

Max

24.85

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-99K

45M

Pardavimai

-98K

476M

P/E

Sektoriaus vid.

19.194

49.052

Dividendų pajamingumas

1.69

Pelno marža

9.55

Darbuotojai

4,193

EBITDA

11M

98M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+20.59% upside

Dividendai

By Acuity

Dividendų pajamingumas

Sektoriaus vid.

1.69%

2.36%

Kitas uždarbis

2026-07-30

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

116M

1.7B

Ankstesnė atidarymo kaina

25.97

Ankstesnė uždarymo kaina

24.35

Naujienos nuotaikos

By Acuity

50%

50%

146 / 342 reitingas Healthcare

Fagron Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Apie bendrovę Fagron

Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide. It operates in three segments: Essentials, Brands, and Compounding Services. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. Its products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; and SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort. In addition, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.
help-icon Live chat